Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
psilocybin
Biotech
Compass, Usona and Transcend score priority vouchers amid psychedelic push
The FDA is awarding national priority vouchers to Compass, Usona and Transcend for their psychedelic treatments.
Will Maddox
Apr 24, 2026 3:51pm
Compass guides psychedelic to 2nd pivotal depression win
Feb 17, 2026 8:39am
Fierce Pharma
Cybin alters state to become Helus Pharma for Nasdaq trip
Dec 19, 2025 10:30am
Reunion's psychedelic reduces postpartum depression in ph. 2
Aug 18, 2025 7:52am
Compass' psychedelic therapy wins ph. 3, investors unimpressed
Jun 23, 2025 8:05am
Psyence walks away from acquisition of fellow psilocybin biotech
Oct 7, 2024 5:16am
